NCT02106130View on ClinicalTrials.gov

A Drug Interaction Study of Mosapride and Rebamipide

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

Rebamipide

oral administration, 3 times/day

DRUG

Mosapride citrate

oral administration, 3 times/day

Trial Locations (1)

120-752

Yonsei University Health System, Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02106130 - A Drug Interaction Study of Mosapride and Rebamipide | Biotech Hunter | Biotech Hunter